Adjunctive Measures for Treating Surgical Infections and Sepsis

Matthew C. Byrnes, Gregory J Beilman

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


The history of adjunctive treatments for severe sepsis has been fraught with more failures than successes. To date, there have been few interventions that have been demonstrated to be efficacious by multiple large, well-designed, multicenter randomized clinical trials. However, recent research into treatment strategies using drotrecogin alfa (activated), effective blood glucose management, early goal-directed therapy, protocolization of care, and intensivist management has demonstrated positive results. Further research is being conducted to verify the success of these initial trials. This article summarizes some of the available adjunctive treatments for severe sepsis.

Original languageEnglish (US)
Pages (from-to)349-363
Number of pages15
JournalSurgical Clinics of North America
Issue number2
StatePublished - Apr 1 2009


  • Activated protein C
  • Adjunctive therapy
  • Glycemic control
  • Sepsis bundles
  • Vasopressors


Dive into the research topics of 'Adjunctive Measures for Treating Surgical Infections and Sepsis'. Together they form a unique fingerprint.

Cite this